US Patent 11572339 Amphetamine carbamate compounds and methods
Patent 11572339 was granted and assigned to Noven Pharmaceuticals on February, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 8 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Apr, 2023
Golden AI
Infobox
Edits on 30 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115723390
Date of Patent
February 7, 2023
0Patent Application Number
175698720
Date Filed
January 6, 2022
0Patent Citations
Patent Primary Examiner
Edits on 23 Mar, 2023
Golden AI
Infobox
Edits on 8 Feb, 2023
Golden AI
Edits made to:
Infobox (+13 properties)
Article (+338 characters)
US Patent 11572339 Amphetamine carbamate compounds and methods
Article
Described herein are the amphetamine-related compounds amphetamine carbamate (amphetammonium-amphetacarbamate) and amphetacarbamate, methods of making them, methods for detecting or quantitatively determining the amount of amphetacarbamate or amphetamine carbamate in a compositions, and ion chromatography columns useful in such methods.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115723390
Date of Patent
February 7, 2023
0Patent Application Number
175698720
Date Filed
January 6, 2022
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11572339 Amphetamine carbamate compounds and methods
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
